SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Anders, H-J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anders, H-J
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Toll for lupus

H-J Anders

Medical Policlinic, Ludwig-Maximilians-University, Munich, Germany, hjanders{at}med.uni-muenchen.de

Toll-like receptor (TLR)-9 recognizes CpG motifs in microbial DNA. TLR9 signalling stimulates innate antimicrobial immunity and modulates adaptive immune responses including autoimmunity against chromatin, e.g., in systemic lupus erythematosus (SLE). This review summarizes the available data for a role of TLR9 signalling in lupus and discusses the following questions that arise from these observations: 1) Is CpG-DNA/TLR9 interaction involved in infection-induced disease activity of lupus? 2) What are the risks of CpG motifs in vaccine adjuvants for lupus patients? 3) Is TLR9 signalling involved in the pathogenesis of lupus by recognizing self DNA?

Key Words: autoimmunity • DNA • infection • inflammation • kidney

Lupus, Vol. 14, No. 6, 417-422 (2005)
DOI: 10.1191/0961203305lu2102rr


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
A.-M. Fairhurst, C. Xie, Y. Fu, A. Wang, C. Boudreaux, X. J. Zhou, R. Cibotti, A. Coyle, J. E. Connolly, E. K. Wakeland, et al.
Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated Glomerulonephritis
J. Immunol., November 15, 2009; 183(10): 6831 - 6838.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. C. Hughes, S. Thomas, C. Li, M.-K. Kaja, and E. A. Clark
Cutting Edge: Progesterone Regulates IFN-{alpha} Production by Plasmacytoid Dendritic Cells
J. Immunol., February 15, 2008; 180(4): 2029 - 2033.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. Nakano, S. Morimoto, J. Suzuki, K. Nozawa, H. Amano, Y. Tokano, and Y. Takasaki
Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus
Rheumatology, February 1, 2008; 47(2): 145 - 149.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
K. Tao, M. Fujii, S.-i. Tsukumo, Y. Maekawa, K. Kishihara, Y. Kimoto, T. Horiuchi, H. Hisaeda, S. Akira, S. Kagami, et al.
Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population
Ann Rheum Dis, July 1, 2007; 66(7): 905 - 909.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. A. Deane and S. Bolland
Nucleic Acid-Sensing TLRs as Modifiers of Autoimmunity
J. Immunol., November 15, 2006; 177(10): 6573 - 6578.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Lartigue, P. Courville, I. Auquit, A. Francois, C. Arnoult, F. Tron, D. Gilbert, and P. Musette
Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus
J. Immunol., July 15, 2006; 177(2): 1349 - 1354.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Verthelyi
Female's Heightened Immune Status: Estrogen, T Cells, and Inducible Nitric Oxide Synthase in the Balance
Endocrinology, February 1, 2006; 147(2): 659 - 661.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. D. Pawar, P. S. Patole, D. Zecher, S. Segerer, M. Kretzler, D. Schlondorff, and H.-J. Anders
Toll-Like Receptor-7 Modulates Immune Complex Glomerulonephritis
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 141 - 149.
[Abstract] [Full Text] [PDF]



Advertisement